XML 173 R41.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment and geographic information (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of significant expense categories by operating segment The table below summarizes the significant expense categories for the life science segment regularly reviewed by the CODM for the years ended December 31, 2024, 2023, and 2022:

Years Ended December 31,

2024

    

2023

    

2022

Total revenues

$

806,780

$

937,822

$

698,801

Less:

Cost of Product Sales

26,901

27,404

15,355

Program Spend

211,230

258,705

292,044

Employee Costs

251,184

334,305

298,716

Manufacturing Costs

64,120

86,641

108,032

Administrative Costs

72,420

70,531

68,001

Occupancy Costs

34,913

42,085

38,260

Milestones

65,000

30,000

Other segment items (a)

444,307

714,755

437,410

Segment Net Loss

$

(363,295)

$

(626,604)

$

(559,017)

Reconciliation of profit or loss

Adjustments and reconciling items

Consolidated Net Loss

$

(363,295)

$

(626,604)

$

(559,017)

(a)Other segment items includes cost of goods sold (“COGS”) amortization of intangible assets, COGS royalty, travel and expense, distribution costs, bad debt expense, finance costs, depreciation and amortization, contract labor costs, stock compensation expense, intangible impairment expense, change in the fair value of contingent consideration, interest expense, net, other income/expense, gain on the sale of the PRV, loss on extinguishment of debt, and income tax expense (benefit).
Summary of financial information based on geographical location

The following table presents financial information based on the geographic location of the facilities of the Company as of and for the years ended:

Year Ended December 31, 2024

    

United States

    

Non-US

    

Total

Total assets

$

1,343,234

$

361,790

$

1,705,024

Fixed assets, net

$

59,748

$

1,222

$

60,970

Revenue

$

413,044

$

393,736

$

806,780

Year Ended December 31, 2023

    

United States

    

Non-US

    

Total

Total assets

$

1,582,962

$

312,736

$

1,895,698

Fixed assets, net

$

86,421

$

668

$

87,089

Revenue

$

531,661

$

406,161

$

937,822